A. Almqvist

530 total citations
8 papers, 140 citations indexed

About

A. Almqvist is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, A. Almqvist has authored 8 papers receiving a total of 140 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 5 papers in Genetics and 3 papers in Oncology. Recurrent topics in A. Almqvist's work include Acute Myeloid Leukemia Research (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Neutropenia and Cancer Infections (2 papers). A. Almqvist is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Neutropenia and Cancer Infections (2 papers). A. Almqvist collaborates with scholars based in Finland, Sweden and United States. A. Almqvist's co-authors include E. Koivunen, Tapani Ruutu, R Lahtinen, M. Lehtinen, Erkki Elonen, P. Koistinen, T. Timonen, Heikki Hallman, Kari Remes and Allan Rajamäki and has published in prestigious journals such as Blood, Leukemia and European Journal Of Haematology.

In The Last Decade

A. Almqvist

8 papers receiving 132 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Almqvist Finland	6	109	46	44	39	33	8	140
Evandro M. Fagundes Brazil	8	121 1.1×	52 1.1×	48 1.1×	32 0.8×	30 0.9×	19	154
Hans‐Joachim Tischler Germany	4	156 1.4×	66 1.4×	45 1.0×	34 0.9×	46 1.4×	4	186
Tomáš Szotkowski Czechia	7	94 0.9×	42 0.9×	27 0.6×	28 0.7×	32 1.0×	36	137
Luis Benlloch Spain	5	149 1.4×	31 0.7×	37 0.8×	24 0.6×	48 1.5×	10	162
Ulrich Germing Germany	3	193 1.8×	121 2.6×	41 0.9×	36 0.9×	60 1.8×	3	228
Sorin Visanica France	6	148 1.4×	59 1.3×	32 0.7×	15 0.4×	67 2.0×	13	161
Jennie B. Feliu United States	6	137 1.3×	107 2.3×	92 2.1×	40 1.0×	29 0.9×	6	219
Katsuhiro Shono Japan	7	71 0.7×	28 0.6×	35 0.8×	26 0.7×	31 0.9×	20	134
Jean-Michel Cayuela France	3	107 1.0×	39 0.8×	38 0.9×	15 0.4×	31 0.9×	6	122
J.-Th. Fischer Germany	5	72 0.7×	52 1.1×	16 0.4×	28 0.7×	17 0.5×	9	101

Countries citing papers authored by A. Almqvist

Since Specialization

Citations

This map shows the geographic impact of A. Almqvist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Almqvist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Almqvist more than expected).

Fields of papers citing papers by A. Almqvist

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Almqvist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Almqvist. The network helps show where A. Almqvist may publish in the future.

Co-authorship network of co-authors of A. Almqvist

This figure shows the co-authorship network connecting the top 25 collaborators of A. Almqvist. A scholar is included among the top collaborators of A. Almqvist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Almqvist. A. Almqvist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Mustjoki, Satu, Marja Ekblom, Auvo Rauhala, et al.. (2007). Clonal Large Granular Lymphocyte (LGL) Expansion Associated with Dasatinib Therapy.. Blood. 110(11). 2938–2938. 7 indexed citations

2.

Ruutu, Tapani, E. Koivunen, T. Nousiainen, et al.. (2003). Oral treatment of acute myeloid leukaemia with etoposide, thioguanine, and idarubicin (ETI) in elderly patients: a prospective randomised comparison with intravenous cytarabine, idarubicin, and thioguanine in the second and third treatment cycle. European Journal Of Haematology. 72(1). 38–44. 8 indexed citations

3.

Elonen, Erkki, A. Almqvist, P. Koistinen, et al.. (1998). Comparison between four and eight cycles of intensive chemotherapy in adult acute myeloid leukemia: a randomized trial of the Finnish Leukemia Group. Leukemia. 12(7). 1041–1048. 35 indexed citations

4.

Rauhala, Auvo, et al.. (1995). [Serum thymidine kinase in the monitoring of lymphoma patients].. PubMed. 111(5). 428–34. 1 indexed citations

5.

Ruutu, Tapani, A. Almqvist, Heikki Hallman, et al.. (1994). Oral induction and consolidation of acute myeloid leukemia with etoposide, 6-thioguanine, and idarubicin (ETI) in elderly patients: a randomized comparison with 5-day TAD. Finnish Leukemia Group.. PubMed. 8(1). 11–5. 40 indexed citations

6.

Palva, I. P., A. Almqvist, Erkki Elonen, et al.. (1991). Value of maintenance therapy with chemotherapy or interferon during remission of acute myeloid leukaemia. European Journal Of Haematology. 47(3). 229–233. 23 indexed citations

7.

Knuutila, Sakari, Erkki Elonen, Kristiina Heinonen, et al.. (1984). Chromosome abnormalities in 16 finnish patients with Burkitt's lymphoma or l3 acute lymphocytic leukemia. Cancer Genetics and Cytogenetics. 13(2). 139–151. 25 indexed citations

8.

Tallqvist, G., Anne Penttilä, A. Almqvist, & S.‐E. Jansson. (1971). TIME SEQUENCE STUDY OF NORADRENALINE DEPLETION OF KIDNEY, SPLEEN AND HEART AND OF JUXTAGLOMERULAR DEGRANULATION IN MICE WITH EHRLICH ASCITES CARCINOMA. Acta Pathologica Microbiologica Scandinavica Section A Pathology. 79A(5). 455–462. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact